Axsome Therapeutics Announces SYMBRAVO®
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing…
Clinical Trial for Post Traumatic Headaches in Adults with History of TBI
Have you had a head injury and experienced headaches ever since? If so, you might have post-traumatic headache (PTH). A…